Health

Aifa approves booster dose with Comirnaty for 12-15 year olds

ADVERTISING


Rome, January 7 – The Technical Scientific Committee (CTS) of Aifa, at its extraordinary meeting on January 5, 2022, at the request of the Ministry of Health, expressed its favorable opinion on the possibility of providing a dose aid vaccine also for people aged 12 to 15 years. Compared to what is already established for the 16-17 age group and for weak people 12-15 years old, this stimulationr should be performed with the vaccine Comirnaty by Pfizer-BioNTech.
With regard to the interval between the initial vaccination cycle and the booster dose, in the absence of specific data for this age group, the CTS considers it reasonable to maintain the same criteria as those adopted in adults. As in any other case, the efficacy and safety data associated with this further extension will be subject to continuous monitoring.

ADVERTISING

Finally, in a note, Aifa reiterates that the primary goal of the vaccination campaign remains the completion of the initial vaccination cycle for the entire eligible population.





Source link

ADVERTISING